Life Sciences Connect

Europe faces substantial challenges in continuing to deliver high-quality healthcare services to its citizens. With growing populations, rigid financing models and rising health inequalities, the conventional, reactive 'sick care' model needs to move to a more proactive, preventative and participatory model of care. Without this transition, by 2040, European healthcare services will face being overwhelmed and unaffordable with diminished access, adversely affecting citizens' health and productivity. Listen to episode 28 of the Life Sciences Connect Podcast to hear our guests dive into the most crucial questions from The Future of Health in Europe report.

Karen and the team explore the findings from the Future of Diagnostic Series.   Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging. 

Karen and the team explore the findings from the Future of Diagnostic Series   Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging. 

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend

In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce. Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State

On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts: Andy Flockhart, UK MedTech Leader Guido Baechler, CEO of Mainz Biomed And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base Listen to hear more on this topic.

Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series

Listen to episode 18 of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds.

Listen to episode 17 of the Life Sciences Connect podcast here where we continue with the Future of Public Health series and dive further into the report- Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees.

In episode sixteen of the Life Science Connect podcast, we dive into the conversation around our fourth report in our Future of Public Health series; Negating the gap - Preventing ill health and promoting healthy behaviours. Joining our host Karen Taylor, Research Director of the Deloitte UK Centre for Health Solutions, is Dr Karen Kirkham, Chief Medical Officer and Lead Partner for Integration in Deloitte’s Health and Social Care team and Sara Siegel, Deloitte’s UK and EMEA Head of Healthcare as we examine the crucial role of public health in health protection, ill-health prevention and in promoting healthy behaviours. Despite a wealth of evidence that investing in prevention is fundamental to a resilient and sustainable health system, the UK, like most other countries, spends less than five per cent of healthcare funding on preventative services. Listen to hear more about this debate and see what some of the experts have to say on this topic

In episode fifteen of the Life Science Connect podcast, we dive into the conversation around our annual R&D Measuring the return from pharmaceutical innovation series report. This report analyses the projected return on investment that biopharma companies can expect to earn from their late-stage pipelines. 

In episode fourteen of the Life Science Connect podcast, we dive into the conversation around planetary health and sustainability in healthcare. Following COP26, it is important that we discuss points around the fundamental risk of climate change and how it impacts our health as well as healthcare delivery and its impact on climate. On this episode of Life Science’s Connect podcast, we discuss these issues further with Deloitte experts on the panel, including: James Gregson: Managing Partner, UK Life Sciences and Healthcare leader and Global Life Sciences and Healthcare ESG leader, Deloitte Lisa Dittmar: Manager, Deloitte’s Net Zero Transformation team, Monitor Deloitte Will Saddlington: Director in the consulting practice, Deloitte And of course, our host, Karen Taylor, Head of The Centre for Health Solutions, Deloitte Our recent future of public health report series includes a report titled “Bridging the gap: Protecting the nation from public health threats”, where we highlight the issues of climate change and the fundamental threat it poses health as well as how healthcare delivery itself impacts the environment. Visit the Life Sciences Connect Podcast homepage to discover more episodes.

In our thirteenth episode of the Life Science Connect podcast series, we discuss the findings from The Future of Public Health Series, covered in the overview report: Narrowing the gap: A fairer and more sustainable future for public health. This first instalment of the series summarises the key takeaways from our research of the challenges pre-pandemic, the impact of COVID-19 and the implications for the future for public health systems in the UK.   Joining our host Karen Taylor, Research Director of the Deloitte UK Centre for Health Solutions, is Karen Kirkham, Chief Medical Officer and Lead Partner for Integration in Deloitte’s Health and Social Care team and Cosima Pettinicchio, Director in Consulting in the Health and Social Care team. 

In our twelfth episode of Life Sciences Connect, our host, Karen Taylor, the Research Director of the Centre for Health Solutions talks to Hanno Ronte, Partner at Monitor Deloitte about consumer research conducted this year on trust in the pharmaceutical industry and explores how COVID-19 has impacted trust, the perception and what role digital can play.  

In our eleventh episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Thomas Croisier, Consulting Partner, Deloitte France; Deborshi Dutt, Consulting Partner, Deloitte UK and Kristina Schapiro, Consulting Director, Deloitte UK to discuss how companies can use AI to improve drug launches and their commercial models.   Visit our Life Sciences Connect Podcast homepage to discover more episodes - https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-connect.html    

In our tenth episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Naveed Panjwani, Director, Consulting, Deloitte and Kevin Dondarski, Senior Manager, Consulting, Deloitte US to discuss research and development. Visit our Life Sciences Connect Podcast homepage to discover more episodes - https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-connect.html      

Our ninth episode of Life Sciences Connect series explores the key trends for the Medtech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and the acceleration of MedTech in healthcare because of COVID-19.\r\n Visit our Life Sciences Connect Podcast homepage to discover more episodes.\r\n  \r\n  \r\n  \r\n  \r\n

James Gregson, our newly appointed UK Life Sciences and Healthcare leader, joins our episode host Samrina Bhatti, to share his thoughts  on what’s next for the industry. James talks about his  leadershipstyle and what makes a good leader as well as his views on digital transformation,collaboration  and developing talent in the Life Sciences and Healthcare industry. Visit our Life Sciences Connect Podcast homepage to discover more episodes.      

What lies ahead for patients, your organisation and your workforce? In this podcast, we explore our predictions for the life sciences and health care industry in 2025, how the pandemic has accelerated industry trends and what this means for you. Our host Karen Taylor, who leads Deloitte Centre for Health Solutions, speaks to  Hanno Ronte, Life Sciences and Healthcare leader Monitor Deloitte, Shivani Maitra, in our Future of Work team, and Sara Siegel, Public Sector Healthcare lead. This episode explores: Key features of the life sciences and healthcare industry in the next 5 years How the legacy of the pandemic has accelerated the  future for all stakeholders in the health ecosystem  The role of collaboration, technology and new skills and talent.    

C-suite leaders in pharmaceutical companies increasingly view Real World Evidence (RWE) as strategically important. RWE enables R&D organisations to prioritise their pipeline investments more effectively, better understand underlying causes of disease and identify opportunities for indication expansion and business development. In the sixth episode of Life Sciences Connect, we explore the role of Real World Evidence in providing insights into existing diagnostic and treatment pathways, identifying unmet need and demonstrating the clinical and economic impact of interventions within the healthcare system. This episode is led by our host Karen Taylor. Karen is joined by Meri Petrovsca, the Knowledge Management Director at AstraZeneca and Seb Burnett, the General Manager of ConvergeHEALTH by Deloitte Europe. This episode explores: The impact of RWE on biopharma companies Implementing knowledge management to maximise Real World Data (RWD) The role of skills and talent in maximising value from RWD and the challenges the industry faces in accessing such talent